BASF & CTIBiotech: Bioprinting Expands to the Sebaceous Glands

Share this Article

If you are starting to get the impression that there is little researchers and innovators cannot do with 3D printing, you are thinking in the right direction—as are so many companies and organizations today like BASF Care Creations and Cell Therapy Research Institute CTIBiotech. This was obvious after their presence at the recent NYSCC Cosmetic Congress where they came together to present research from a collaboration regarding a stunning new method for bioprinting.

BASF and CTIBiotech have been working together to advance further in skin care applications, now coming forth with technology for the bioprinting of tissue to create sebaceous glands.

“Working with BASF allowed us to validate a powerful technology for human skin care research in very little time. This positions CTIBiotech as a world leader in innovative and even disruptive technologies for human cell-based bioassays, applied to dermo-cosmetics,” said CTIBiotech CEO Dr. Nico Forraz.

[Image: BASF]

For two years the companies have been researching 3D tissue models for testing bio-actives that are appropriate for skin care applications, resulting in the following:

  • Ex vivo production of physiological sebum in a bioprinted culture
  • Regulation of the sebum production with active ingredients

The researchers were able to refine the BASF 3D skin model portfolio further thanks to CTIBiotech’s 3D human sebaceous gland technology, which offers a new way for everyone to study sebaceous glands and how they function—especially in research relevant to skin disorders that may be caused by age or microbial issues or inflammation.

“Compared to current in vitro methods, the 3D models developed by CTIBiotech allow analysis more in touch with human physiology and sebaceous gland metabolism,” said BASF’s project lead Dr. Sabine Pain. “That’s how their technology helps us accelerate the development of innovative and highly reliable ingredients for the skin care market. Our understanding of sebaceous gland metabolism provides the basis for developing and testing advanced cosmetic bio-actives for skincare applications, and in particular skincare products for oily skin.”

CTIBiotech is headquartered in France, and has an intensive focus on specialties in biotechnologies for advancing cancer, stem cell, and tissue engineering research. They also make both in vitro and ex vivo cell models for medical and other research, along with innovative medical devices for cell therapy. BASF is focused on research centered around five segments: chemicals, performance products, functional materials and solutions, agricultural solutions, and oil and gas. This latest collaboration should pave the way for many researchers to move forward into unchartered territory for bioprinting.

“Because of their experience and expertise in developing solutions for the dermo-cosmetics market, BASF understands the benefits of collaborating with tissue engineering experts,” added Professor Colin McGuckin, Chief Scientific Officer and President of CTIBiotech. “The next evolution of the sebaceous gland model will be based on a 3D bio-printing technology that allows us to fully reproduce micro-glands into a full thickness skin model, in vitro.”

BASF has been increasing its work with 3D printing technologies, including study of 3D printed skin and the recent establishment of a dedicated 3D printing business.

What do you think of this news? Let us know your thoughts! Join the discussion of this and other 3D printing topics at 3DPrintBoard.com or share your thoughts below.

[Source: BASF]

 

Facebook Comments

Share this Article


Related Articles

Impossible Objects Makes Presence Known at RAPID + TCT with CBAM-2 3D Printing System, BASF Collaboration on Materials

RAPID 2019: BASF, Origin and ECCO Partner to Produce Footwear



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

HP: Announces Siemens Collaboration, Releases Jet Fusion 5200 Series, Plus New Software and Materials

“The Fourth Industrial Revolution is one of the most transformative forces in our lifetime. New technology innovations will be required, new partnership models will emerge, and new modes of doing...

$22 Million BASF and Materialise Essentium Investment, Analysis and Comment

BASF Venture Capital along with Materialise and Genesis Park (the Houston based VC not the park that purportedly gives us evidence that Man and Dinosaurs coexisted) closed their $22.2 million investment...

Interview with Origin 3D Printing CEO Chris Prucha

Origin launched while announcing an “Open Additive Production“…platform…”a new way to build based on open materials, extensible software, and modular hardware” and a simultaneous partnership with BASF to develop materials...

BASF, Essentium and Materialise Partner to Accelerate Industrial Additive Manufacturing

For more than a year, BASF and Essentium have been working together to develop advanced 3D printing materials with high mechanical strength, using Essentium’s proprietary FlashFuse technology. The two companies are now...


Training


Shop

View our broad assortment of in house and third party products.


Print Services

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our 3DPrint.com.

You have Successfully Subscribed!